TAK-733 | Interleukin Related interleukin-related.com

Product Name :
TAK-733

Search keywords :
TAK-733

drugId :
null

Target Vo:
Dual specificity mitogen-activated protein kinase kinase 1

Target Vo Short Name :
MEK1

Moa_Name:
Dual specificity mitogen-activated protein kinase kinase 1 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Takeda

Active Company_Name :
Recursion Pharmaceuticals Inc

Active Indication_Name:
Solid tumours

In Active Indication_Name:
Stomach Neoplasms

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Bak Antibody (YA592)
Phospho-mTOR (Ser2481) Antibody
Clenbuterol Antibody (YA904): Clenbuterol Antibody (YA904) is an unconjugated, rabbit-derived, anti-Clenbuterol (YA904) monoclonal antibody. Clenbuterol Antibody (YA904) can be used for: ELISA expriments in background without labeling.

Author: Interleukin Related

Related Posts